Regulatory changes since then have tightened scrutiny on such transactions. But controversies over such transactions at companies ranging from drugmaker Sun Pharmaceutical Industries to India’s largest airline brand Indigo suggest that the matter is far from resolved.
How to improve
- Modify the 10 per cent threshold to include other relevant ratios
- Shareholders can avoid omnibus approvals
- Disclose all related-party transactions, irrespective of size
- Subject transactions to external audit
- Plug loopholes between the Sebi regulations and the Companies Act
One subscription. Two world-class reads.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)